Related Experiment Videos
Selecting chemotherapy for metastatic breast cancer
Postgraduate Medicine
|March 1, 1976
Abstract:
When cytotoxic chemotherapy is indicated in metastatic breast cancer, usually a combination of an alkylating agent and an antimetabolite, with or without doxorubicin, is used. The combinations including doxorubicin appear to give the best response rate.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole.
Annals of oncology : official journal of the European Society for Medical Oncology·2012
Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.
Annals of oncology : official journal of the European Society for Medical Oncology·2008
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology·2005
The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)·2002
Ponatinib in CML and Ph+ ALL: balancing high efficacy with vascular safety.
Postgraduate medicine·2026
CV risk: if you aren't testing ACR, you aren't seeing the full picture.
Postgraduate medicine·2026
Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.
Postgraduate medicine·2026
Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?
Clinical and translational radiation oncology·2026